In Brief: Chattem
This article was originally published in The Rose Sheet
Executive Summary
Chattem: Sales for the third quarter of 1996 (ended Aug. 31) advanced 34% to $38.8 mil., the company reported Sept. 17. Operating income for the three months climbed 32.1% to $6.9 mil. over the prior-year period and net earnings increased 27.4% to $2.1 mil. The company pointed to pHisoderm Antibacterial Skin Cleanser, which was introduced in May, the launch of Flex All Ultra Plus and the restaging of the existing Flex All line as factors in the sales increase. During the quarter, Chattem also completed the acquisition of Herpecin-L cold sore lip balm from Deerfield, Fla.-based Campbell Labs. For 1997, new line extensions are planned, with "major efforts" slated for Gold Bond and Icy Hot, the company said...